Join
Live feed
·
PRReleasevia Quantisnow
Hoth Therapeutics Inc. logo

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide

ByQuantisnow·Wall Street's wire, on your screen.
HOTH· Hoth Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HOTH (Hoth Therapeutics Inc.) and more on Quantisnow.